225 related articles for article (PubMed ID: 31319422)
1. Cleft Palate as Distinguishing Feature in a Patient with GABRB3 Epileptic Encephalopathy.
Bamborschke D; Pergande M; Daimagüler HS; Mangold E; Dötsch J; Herkenrath P; Cirak S; Fazeli W
Neuropediatrics; 2019 Dec; 50(6):378-381. PubMed ID: 31319422
[TBL] [Abstract][Full Text] [Related]
2. GABRB3 mutations: a new and emerging cause of early infantile epileptic encephalopathy.
Papandreou A; McTague A; Trump N; Ambegaonkar G; Ngoh A; Meyer E; Scott RH; Kurian MA
Dev Med Child Neurol; 2016 Apr; 58(4):416-20. PubMed ID: 26645412
[TBL] [Abstract][Full Text] [Related]
3. Rare GABRA3 variants are associated with epileptic seizures, encephalopathy and dysmorphic features.
Niturad CE; Lev D; Kalscheuer VM; Charzewska A; Schubert J; Lerman-Sagie T; Kroes HY; Oegema R; Traverso M; Specchio N; Lassota M; Chelly J; Bennett-Back O; Carmi N; Koffler-Brill T; Iacomino M; Trivisano M; Capovilla G; Striano P; Nawara M; Rzonca S; Fischer U; Bienek M; Jensen C; Hu H; Thiele H; Altmüller J; Krause R; May P; Becker F; ; Balling R; Biskup S; Haas SA; Nürnberg P; van Gassen KLI; Lerche H; Zara F; Maljevic S; Leshinsky-Silver E
Brain; 2017 Nov; 140(11):2879-2894. PubMed ID: 29053855
[TBL] [Abstract][Full Text] [Related]
4. De novo variants in GABRA2 and GABRA5 alter receptor function and contribute to early-onset epilepsy.
Butler KM; Moody OA; Schuler E; Coryell J; Alexander JJ; Jenkins A; Escayg A
Brain; 2018 Aug; 141(8):2392-2405. PubMed ID: 29961870
[TBL] [Abstract][Full Text] [Related]
5. Early onset epileptic encephalopathy with a novel GABRB3 mutation treated effectively with clonazepam: A case report.
Zhang Y; Lian Y; Xie N
Medicine (Baltimore); 2017 Dec; 96(50):e9273. PubMed ID: 29390378
[TBL] [Abstract][Full Text] [Related]
6. Mutations in GABRB3: From febrile seizures to epileptic encephalopathies.
Møller RS; Wuttke TV; Helbig I; Marini C; Johannesen KM; Brilstra EH; Vaher U; Borggraefe I; Talvik I; Talvik T; Kluger G; Francois LL; Lesca G; de Bellescize J; Blichfeldt S; Chatron N; Holert N; Jacobs J; Swinkels M; Betzler C; Syrbe S; Nikanorova M; Myers CT; Larsen LH; Vejzovic S; Pendziwiat M; von Spiczak S; Hopkins S; Dubbs H; Mang Y; Mukhin K; Holthausen H; van Gassen KL; Dahl HA; Tommerup N; Mefford HC; Rubboli G; Guerrini R; Lemke JR; Lerche H; Muhle H; Maljevic S
Neurology; 2017 Jan; 88(5):483-492. PubMed ID: 28053010
[TBL] [Abstract][Full Text] [Related]
7. De novo GABRG2 mutations associated with epileptic encephalopathies.
Shen D; Hernandez CC; Shen W; Hu N; Poduri A; Shiedley B; Rotenberg A; Datta AN; Leiz S; Patzer S; Boor R; Ramsey K; Goldberg E; Helbig I; Ortiz-Gonzalez XR; Lemke JR; Marsh ED; Macdonald RL
Brain; 2017 Jan; 140(1):49-67. PubMed ID: 27864268
[TBL] [Abstract][Full Text] [Related]
8. Synaptic clustering differences due to different GABRB3 mutations cause variable epilepsy syndromes.
Shi YW; Zhang Q; Cai K; Poliquin S; Shen W; Winters N; Yi YH; Wang J; Hu N; Macdonald RL; Liao WP; Kang JQ
Brain; 2019 Oct; 142(10):3028-3044. PubMed ID: 31435640
[TBL] [Abstract][Full Text] [Related]
9. Early-onset epileptic encephalopathy with hearing loss in two siblings with TBC1D24 recessive mutations.
Stražišar BG; Neubauer D; Paro Panjan D; Writzl K
Eur J Paediatr Neurol; 2015 Mar; 19(2):251-6. PubMed ID: 25557349
[TBL] [Abstract][Full Text] [Related]
10. Severe early-onset epileptic encephalopathy due to mutations in the KCNA2 gene: Expansion of the genotypic and phenotypic spectrum.
Hundallah K; Alenizi A; AlHashem A; Tabarki B
Eur J Paediatr Neurol; 2016 Jul; 20(4):657-60. PubMed ID: 27117551
[TBL] [Abstract][Full Text] [Related]
11. GABRB3-related epilepsy: novel variants, clinical features and therapeutic implications.
Yang Y; Zeng Q; Cheng M; Niu X; Xiangwei W; Gong P; Li W; Ma J; Zhang X; Yang X; Yang Z; Sun D; Zhou S; Liao J; Jiang Y; Zhang Y
J Neurol; 2022 May; 269(5):2649-2665. PubMed ID: 34698933
[TBL] [Abstract][Full Text] [Related]
12. Neonatal Onset of Epilepsy of Infancy with Migrating Focal Seizures Associated with a Novel GABRB3 Variant in Monozygotic Twins.
Štěrbová K; Vlčková M; Klement P; Neupauerová J; Staněk D; Zůnová H; Seeman P; Laššuthová P
Neuropediatrics; 2018 Jun; 49(3):204-208. PubMed ID: 29444535
[TBL] [Abstract][Full Text] [Related]
13. A mutation in GABRB3 associated with Dravet syndrome.
Le SV; Le PHT; Le TKV; Kieu Huynh TT; Hang Do TT
Am J Med Genet A; 2017 Aug; 173(8):2126-2131. PubMed ID: 28544625
[TBL] [Abstract][Full Text] [Related]
14. GABA
Nwosu GI; Shen W; Zavalin K; Poliquin S; Randhave K; Flamm C; Biven M; Langer K; Kang JQ
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37176165
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic spectrum of patients with GABRB2 variants: from mild febrile seizures to severe epileptic encephalopathy.
Yang Y; Xiangwei W; Zhang X; Xiao J; Chen J; Yang X; Jia T; Yang Z; Jiang Y; Zhang Y
Dev Med Child Neurol; 2020 Oct; 62(10):1213-1220. PubMed ID: 32686847
[TBL] [Abstract][Full Text] [Related]
16. [Clinical phenotypes of epilepsy associated with GABRA1 gene variants].
Yang Y; Zhang YH; Chen JY; Ma JH; Sun D; Yang XL; Zhang J; Chen Y; Wu XR
Zhonghua Er Ke Za Zhi; 2020 Feb; 58(2):118-122. PubMed ID: 32102148
[No Abstract] [Full Text] [Related]
17. A patient with early myoclonic encephalopathy (EME) with a de novo KCNQ2 mutation.
Kojima K; Shirai K; Kobayashi M; Miyauchi A; Saitsu H; Matsumoto N; Osaka H; Yamagata T
Brain Dev; 2018 Jan; 40(1):69-73. PubMed ID: 28687180
[TBL] [Abstract][Full Text] [Related]
18. Epileptic patients with de novo STXBP1 mutations: Key clinical features based on 24 cases.
Di Meglio C; Lesca G; Villeneuve N; Lacoste C; Abidi A; Cacciagli P; Altuzarra C; Roubertie A; Afenjar A; Renaldo-Robin F; Isidor B; Gautier A; Husson M; Cances C; Metreau J; Laroche C; Chouchane M; Ville D; Marignier S; Rougeot C; Lebrun M; de Saint Martin A; Perez A; Riquet A; Badens C; Missirian C; Philip N; Chabrol B; Villard L; Milh M
Epilepsia; 2015 Dec; 56(12):1931-40. PubMed ID: 26514728
[TBL] [Abstract][Full Text] [Related]
19. Novel variants and phenotypes widen the phenotypic spectrum of GABRG2-related disorders.
Komulainen-Ebrahim J; Schreiber JM; Kangas SM; Pylkäs K; Suo-Palosaari M; Rahikkala E; Liinamaa J; Immonen EV; Hassinen I; Myllynen P; Rantala H; Hinttala R; Uusimaa J
Seizure; 2019 Jul; 69():99-104. PubMed ID: 31004928
[TBL] [Abstract][Full Text] [Related]
20. GRIN1 mutations cause encephalopathy with infantile-onset epilepsy, and hyperkinetic and stereotyped movement disorders.
Ohba C; Shiina M; Tohyama J; Haginoya K; Lerman-Sagie T; Okamoto N; Blumkin L; Lev D; Mukaida S; Nozaki F; Uematsu M; Onuma A; Kodera H; Nakashima M; Tsurusaki Y; Miyake N; Tanaka F; Kato M; Ogata K; Saitsu H; Matsumoto N
Epilepsia; 2015 Jun; 56(6):841-8. PubMed ID: 25864721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
